Previous close | 44.52 |
Open | 43.81 |
Bid | 43.63 x 100 |
Ask | 43.88 x 100 |
Day's range | 41.75 - 44.37 |
52-week range | 24.31 - 64.98 |
Volume | |
Avg. volume | 470,491 |
Market cap | 2.745B |
Beta (5Y monthly) | 1.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Details on Clinical Advances and Financial Health Amidst Ongoing Research and Development Efforts
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Biotech stock MoonLake popped Monday after the company said its experimental psoriatic arthritis treatment beat out AbbVie's Humira.